P2.35: Nivolumab vs Docetaxel in Advanced NSCLC: CheckMate 017/057 2-Y Update and Exploratory Cytokine Profile Analysis Hossein Borghaei, Julie Brahmer,

Slides:

Advertisements

Similar presentations

Julie Brahmer, M. D. , Karen L. Reckamp, M. D. , Paul Baas, M. D

Advertisements

SC17.02 Lung Cancer in China: Challenges and Perspectives

Journal of Thoracic Oncology Volume 11, Issue 4, Pages (April 2016)

MA09.05 Nivolumab Alone or with Ipilimumab in Recurrent Small Cell Lung Cancer (SCLC): 2-Year Survival and Updated Analyses from the Checkmate 032 Trial

PL03.07: First-line Ceritinib Versus Chemotherapy in Patients with ALK-rearranged (ALK+) NSCLC: A Randomized, Phase 3 Study (ASCEND-4) Gilberto De Castro,

Susan C. Scott, MD, Nathan A. Pennell, MD, PhD

Journal of Thoracic Oncology Volume 12, Issue 3, Pages (March 2017)

Electronic Updates for JTO Readers

IA05.01 Lung Cancer Cases Journal of Thoracic Oncology

P Transcriptional Profiling Identified the Anti-Proliferative Effect of Mitofusin-2 Deficiency and Its Risk in Lung Adenocarcinoma Yuqing Lou,

P3.02c-030 Use of a 200-Mg Fixed Dose of Pembrolizumab for the Treatment of Advanced Non–Small Cell Lung Cancer (NSCLC) Edward Garon, Martin Reck, Delvys.

P The Effect of Two Interventions on Attainment of Surgical Quality Measures in Resected Non-Small Cell Lung Cancer (NSCLC) Nicholas Faris, Meredith.

P The Impact of IASLC 8th Edition Updates for T-Classification for Lung Cancer in a US Population-Based Surgical Resection Cohort Matthew Smeltzer,

P2.33: Safety Profile of Nivolumab Administered as 30-Minute (MIN) Infusion: Analysis of Data From Checkmate 153 David Waterhouse, Leora Horn, Craig.

Journal of Thoracic Oncology Volume 12, Issue 5, Pages (May 2017)

Confessions of a journal junkie

Journal of Thoracic Oncology Volume 13, Issue 2, Pages (February 2018)

P SARON: Stereotactic Ablative Radiotherapy for Oligometastatic Non-Small Cell Lung Cancer (NSCLC). A UK Randomized Phase III Trial Yenting Ngai,

P3.02c-026 Is Nivolumab Safe and Effective in Elderly and PS2 Patients with Non-Small Cell Lung Cancer (NSCLC)? Results of CheckMate 153 David Spigel,

PS01.59: CheckMate 370: A Master Protocol of Phase 1/2 Studies of Nivolumab as Maintenance or First-Line ± Standard-of-Care Therapies in Advanced NSCLC

P3.02b-075 Addition of Bevacizumab for Malignant Pleural Effusion as the Manifestation of Acquired EGFR-TKI Resistance in NSCLC Patients Tao Jiang, Shengxiang.

In This Issue Journal of Thoracic Oncology

P ISEND May Predict Clinical Outcomes for Advanced NSCLC Patients on PD- 1/PD-L1 Inhibitors but Not Chemotherapies or Targeted Kinase Inhibitors

Journal of Thoracic Oncology Volume 11, Issue 2, Pages (February 2016)

P3.02b-062 Safety of Necitumumab and Abemaciclib Combination Therapy in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) Benjamin Besse, Johan.

Support Your Specialty

P1.22: Temporal Survival Improvement for Stage-II (T3N0M0) Lung Adenocarcinoma After Pulmonary Lobectomy Danny T. Nguyen, Jacques-Pierre Fontaine, Lary.

Journal of Thoracic Oncology Volume 12, Issue 7, Pages (July 2017)

Nivolumab-Induced Acute Diabetes Mellitus and Hypophysitis in a Patient with Advanced Pulmonary Pleomorphic Carcinoma with a Prolonged Tumor Response

Journal of Thoracic Oncology Volume 12, Issue 8, Pages (August 2017)

ED11.01 Systemic Therapy for Advanced Oncogene-Driven NSCLC

MA04.02 Neratinib ± Temsirolimus in HER2-Mutant Lung Cancers: An International, Randomized Phase II Study Leena Gandhi, Benjamin Besse, Julien Mazieres,

JCSE01.16 Positive Correlation Between Whole Genomic Copy Number Variant Scoring and the Grading System in Lung Non-Mucinous Invasive Adenocarcinoma

Journal of Thoracic Oncology Volume 11, Issue 10, Pages (October 2016)

Journal of Thoracic Oncology Volume 12, Issue 10, Pages (October 2017)

P Circulating Biomarkers of Frailty Are Associated with a Poor Prognosis in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) Nicola.

P Comparison of Pulmonary Function after Robotic-Assisted Video- Thoracoscopic Lobectomies vs Segmentectomies Maria Echavarria, Anna Cheng, Frank.

Nivolumab-Induced Granulomatous Inflammation of the Pleura

Journal of Thoracic Oncology Volume 11, Issue 5, Pages (May 2016)

Journal of Thoracic Oncology Volume 11, Issue 8, Pages (August 2016)

Journal of Thoracic Oncology

P3.02b-052 Afatinib with or without Cetuximab for First-Line Treatment of EGFR-Mutant NSCLC: Interim Safety Results of SWOG S1403 Sarah Goldberg, James.

M. Kusumoto Journal of Thoracic Oncology

OA07.06 In Early-Stage Lung Adenocarcinomas, Survival by Tumor Size (T) is Further Stratified by Tumor Spread through Air Spaces Takashi Eguchi, Koji.

Table of Contents Journal of Thoracic Oncology

MA12.05 Can Tumor Spread through Air Spaces (STAS) in Lung Adenocarcinomas Be Predicted Pre- and Intraoperatively? Koji Kameda, Shaohua Lu, Takashi Eguchi,

OA12.05 Vemurafenib in Patients Harboring V600 and Non V600 BRAF Mutations: Final Results of the NSCLC Cohort from the AcSé Trial. J. Mazieres, L. Montané,

Journal of Thoracic Oncology Volume 13, Issue 3, Pages (March 2018)

P Impact of Systematic EBUS-TBNA Mediastinal Staging on Radical Radiotherapy Planning in NSCLC N. Hardcastle, A. Cole, G. Turgeon, R. Thomas,

P Implications of 8th Edition TNM Proposal: Invasive vs

OA Video-Assisted Thoracoscopic Surgery vs

Health-Related Quality of Life in KEYNOTE-010: a Phase II/III Study of Pembrolizumab Versus Docetaxel in Patients With Previously Treated Advanced, Programmed.

MA02.10 The First Year of Implementing a Lung Cancer Screening Program in an Urban Safety-Net Health System H. Hamann, S. Lee, T. Browning, C. Chavez,

P2.41 (also presented as PD1.06): Pembrolizumab vs Docetaxel for Previously Treated NSCLC (KEYNOTE-010): Archival vs New Tumor Samples for PD-L1 Assessment

P Combined Molecular and Radiological Evaluation Unveils Three Subtypes of Disease Progression to a Third Generation EGFR TKI Y. Zhang, Q. Zhou,

Journal of Thoracic Oncology Volume 13, Issue 6, Pages (June 2018)

Third-Line Nivolumab Monotherapy in Recurrent SCLC: CheckMate 032

PS01.07 The Clinical Necessity of Extended Thymectomy for Thymic Squamous Cell Carcinomas Revealed by Exome Sequencing J. Jiang, Y. Zhang, C. Jin, J.

Journal of Thoracic Oncology

IASLC 6th Latin American Conference on Lung Cancer

PS01.37: Comparison Between Sanger Sequencing and ARMS qPCR Method for EGFR Gene Mutation Detection of Non–Small Cell Lung Cancer Jiexia Zhang, Xiaoshun.

Safety and Efficacy of First-Line Bevacizumab Plus Chemotherapy in Elderly Patients with Advanced or Recurrent Nonsquamous Non-small Cell Lung Cancer:

P Clinical Consequences, Quality of Life, and Management of Neutropenic NSCLC Patients in the REVEL Trial D. Ettinger, O. Arrieta, N. Karaseva,

P1.15: Comparison of Pulmonary Function After Robotic-Assisted Video-Thoracoscopic Lobectomies vs Segmentectomies Maria F. Echavarria, Anna Cheng, Frank.

P1. 02: Lung Cancer - A Previously Years Survival Study

Mark A. Socinski, MD Journal of Thoracic Oncology

Economic Analysis of First-Line Treatment with Erlotinib in an EGFR-Mutated Population with Advanced NSCLC Alain Vergnenegre, MD, PhD, Bartomeu Massuti,

Y. Lou, R. Manochakian, J. Cochuyt, D. Hodge, S. Ailawadhi

Robert Comis, MD, The Passing of a “Lung Man”

ED04.01 Surgery in Bronchopulmonary Typical and Atypical Carcinoids

Presentation transcript:

P2.35: Nivolumab vs Docetaxel in Advanced NSCLC: CheckMate 017/057 2-Y Update and Exploratory Cytokine Profile Analysis Hossein Borghaei, Julie Brahmer, Leora Horn, Neal Ready, Martin Steins, Enriqueta Felip, Luis Paz-Ares, Xx Xx, Fabrice Barlesi, Scott Antonia, Jérome Fayette, Naiyer Rizvi, Lucio Crino, Martin Reck, Wilfried Ernst Erich Eberhardt, Matthew Hellmann, Kaushal Desai, Ang Li, Diane Healey, David Spigel, Clarissa Mathias Journal of Thoracic Oncology Volume 11, Issue 10, Pages S237-S238 (October 2016) DOI: 10.1016/j.jtho.2016.08.106 Copyright © 2016 Terms and Conditions

Journal of Thoracic Oncology 2016 11, S237-S238DOI: (10. 1016/j. jtho Copyright © 2016 Terms and Conditions